We have consistently showed that Sema3A reduced the motility of a panel of osteosarcoma cell lines including KHOS, consistent with the anti-migratory action of osteosarcoma-derived Sema3A and the action of Sema3A previously reported in both neuronal and cancer cells11–15,19–24. The gene discussed is SEMA3A; the disease is osteosarcoma.